CD47 and neoplasm: To assess antigen-specific T cell responses against melanoma in vivo, mice engrafted with B16-OVA tumours received two injections of PBS, anti-CD47 antibody (MIAP301), or isotype control antibody (Supplemental digital content 2, http://links.lww.com/MR/A159).